Clinical Trial Update: Personalized DC Vaccine for Postoperative Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a personalized dendritic cell vaccine for postoperative gastric cancer and hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Personalized dendritic cell vaccine (Autologous dendritic cell vaccine pulsed with tumor antigens)

Snippet

Sponsor: Sichuan University | Conditions: Gastric Cancer, Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING